mirtazapine has been researched along with Panic Attacks in 13 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this open label trial was to evaluate mirtazapine tolerability and effectiveness in controlling symptomatology of patients with panic disorder." | 9.10 | Mirtazapine in the treatment of panic disorder: an open-label trial. ( Amore, M; Balista, C; Camardese, G; Carli, V; De Risio, S; Faia, V; Ferrari, G; Poterzio, F; Sarchiapone, M, 2003) |
| "Mirtazapine is an antidepressant whose side effect profile differs from that of first-line agents (selective serotonin reuptake inhibitors) used in the treatment of panic disorder." | 9.09 | Mirtazapine versus fluoxetine in the treatment of panic disorder. ( Busnello, EA; Busnello, JV; Kapczinski, F; Kauer-Sant'Anna, M; Madruga, M; Quevedo, J; Ribeiro, L, 2001) |
| "In this open label pilot study, we studied the efficacy of mirtazapine (Remeron) in panic disorder." | 9.09 | The effect of mirtazapine in panic disorder: an open label pilot study with a single-blind placebo run-in period. ( Boshuisen, ML; den Boer, JA; Slaap, BR; Vester-Blokland, ED, 2001) |
| " This report presents the beneficial effect of low-dose mirtazapine added onto selective serotonin reuptake inhibitors in the treatment of the symptoms of severe nausea, insomnia and loss of appetite accompanying psychiatric disorders during pregnancy, which is an important problem in clinical practice." | 7.79 | Low-dose mirtazapine added to selective serotonin reuptake inhibitors in pregnant women with major depression or panic disorder including symptoms of severe nausea, insomnia and decreased appetite: three cases. ( Uguz, F, 2013) |
| "The aim of this open label trial was to evaluate mirtazapine tolerability and effectiveness in controlling symptomatology of patients with panic disorder." | 5.10 | Mirtazapine in the treatment of panic disorder: an open-label trial. ( Amore, M; Balista, C; Camardese, G; Carli, V; De Risio, S; Faia, V; Ferrari, G; Poterzio, F; Sarchiapone, M, 2003) |
| "Mirtazapine is an antidepressant whose side effect profile differs from that of first-line agents (selective serotonin reuptake inhibitors) used in the treatment of panic disorder." | 5.09 | Mirtazapine versus fluoxetine in the treatment of panic disorder. ( Busnello, EA; Busnello, JV; Kapczinski, F; Kauer-Sant'Anna, M; Madruga, M; Quevedo, J; Ribeiro, L, 2001) |
| "In this open label pilot study, we studied the efficacy of mirtazapine (Remeron) in panic disorder." | 5.09 | The effect of mirtazapine in panic disorder: an open label pilot study with a single-blind placebo run-in period. ( Boshuisen, ML; den Boer, JA; Slaap, BR; Vester-Blokland, ED, 2001) |
| "Current studies do not yet provide convincing evidence supporting the efficacy of mirtazapine, reboxetine, milnacipran and duloxetine for the treatment of panic disorder patients." | 4.87 | Novel antidepressants and panic disorder: evidence beyond current guidelines. ( Bellodi, L; Calati, R; Chiesa, A; De Ronchi, D; Perna, G; Serretti, A, 2011) |
| " This report presents the beneficial effect of low-dose mirtazapine added onto selective serotonin reuptake inhibitors in the treatment of the symptoms of severe nausea, insomnia and loss of appetite accompanying psychiatric disorders during pregnancy, which is an important problem in clinical practice." | 3.79 | Low-dose mirtazapine added to selective serotonin reuptake inhibitors in pregnant women with major depression or panic disorder including symptoms of severe nausea, insomnia and decreased appetite: three cases. ( Uguz, F, 2013) |
| "Mirtazapine is an antidepressant with mode of action different from other currently available antidepressants." | 2.40 | Mirtazapine: other indications. ( Falkai, P, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Uvais, NA | 1 |
| Sasao, A | 1 |
| Yonemitsu, K | 1 |
| Ohtsu, Y | 1 |
| Tsutsumi, H | 1 |
| Furukawa, S | 1 |
| Kimura-Mishima, S | 1 |
| Nishitani, Y | 1 |
| Serretti, A | 1 |
| Chiesa, A | 1 |
| Calati, R | 1 |
| Perna, G | 1 |
| Bellodi, L | 1 |
| De Ronchi, D | 1 |
| Udo, I | 1 |
| Gash, A | 1 |
| Uguz, F | 1 |
| Sarchiapone, M | 2 |
| Amore, M | 1 |
| De Risio, S | 1 |
| Carli, V | 2 |
| Faia, V | 1 |
| Poterzio, F | 1 |
| Balista, C | 1 |
| Camardese, G | 2 |
| Ferrari, G | 1 |
| Carpenter, LL | 1 |
| Leon, Z | 1 |
| Yasmin, S | 1 |
| Price, LH | 1 |
| Falkai, P | 1 |
| Klesmer, J | 1 |
| Sarcevic, A | 1 |
| Fomari, V | 1 |
| Ribeiro, L | 1 |
| Busnello, JV | 1 |
| Kauer-Sant'Anna, M | 1 |
| Madruga, M | 1 |
| Quevedo, J | 1 |
| Busnello, EA | 1 |
| Kapczinski, F | 1 |
| Boshuisen, ML | 2 |
| Slaap, BR | 2 |
| Vester-Blokland, ED | 1 |
| den Boer, JA | 2 |
| van Roon, AM | 1 |
| Romano, L | 1 |
| DeRisio, S | 1 |
2 reviews available for mirtazapine and Panic Attacks
| Article | Year |
|---|---|
Novel antidepressants and panic disorder: evidence beyond current guidelines.
Topics: Antidepressive Agents; Clinical Trials as Topic; Cyclopropanes; Duloxetine Hydrochloride; Humans; Mi | 2011 |
Mirtazapine: other indications.
Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety Disorders; Clinical Trials as Topic; Depressive Dis | 1999 |
6 trials available for mirtazapine and Panic Attacks
| Article | Year |
|---|---|
Mirtazapine in the treatment of panic disorder: an open-label trial.
Topics: Adult; Comorbidity; Depressive Disorder; Female; Histamine H1 Antagonists; Humans; Male; Mianserin; | 2003 |
Clinical experience with mirtazapine in the treatment of panic disorder.
Topics: Adult; Ambulatory Care; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Drug Administration | 1999 |
Mirtazapine versus fluoxetine in the treatment of panic disorder.
Topics: Adolescent; Adult; Analysis of Variance; Antidepressive Agents, Tricyclic; Double-Blind Method; Fema | 2001 |
The effect of mirtazapine in panic disorder: an open label pilot study with a single-blind placebo run-in period.
Topics: Adult; Antidepressive Agents, Tricyclic; Female; Humans; Male; Mianserin; Mirtazapine; Panic Disorde | 2001 |
Heart rate variability as predictor of nonresponse to mirtazapine in panic disorder: a preliminary study.
Topics: Adult; Agoraphobia; Antidepressive Agents, Tricyclic; Electrocardiography; Female; Heart Rate; Human | 2002 |
Mirtazapine in the treatment of panic disorder.
Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Female; Gyrus Cinguli; Hippocampus; Humans; Mal | 2002 |
5 other studies available for mirtazapine and Panic Attacks
| Article | Year |
|---|---|
Psychological Impact of the COVID-19 Pandemic Among the Elderly: A Case Series From India.
Topics: Acetamides; Aged; Aged, 80 and over; Anti-Anxiety Agents; Antidepressive Agents; Betacoronavirus; Ci | 2020 |
High blood mirtazapine concentration in a newborn - A case of suspected postpartum infanticide.
Topics: Adult; Chromatography, Liquid; Depression, Postpartum; Female; Forensic Medicine; Homicide; Humans; | 2021 |
Challenges in management of complex panic disorder in a palliative care setting.
Topics: Anti-Anxiety Agents; Anxiety; Breathing Exercises; Comorbidity; Death; Dibenzothiazepines; Eye Movem | 2012 |
Low-dose mirtazapine added to selective serotonin reuptake inhibitors in pregnant women with major depression or panic disorder including symptoms of severe nausea, insomnia and decreased appetite: three cases.
Topics: Adult; Antidepressive Agents, Tricyclic; Depression; Dose-Response Relationship, Drug; Feeding and E | 2013 |
Panic attacks during discontinuation of mirtazepine.
Topics: Antidepressive Agents, Tricyclic; Appendectomy; Dysthymic Disorder; Hernia, Umbilical; Humans; Male; | 2000 |